Skip to content

Clinical trials

Phase 2 Diabetes Mellitus trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 2 Country / region: United Kingdom Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20032
20041
20073
20081
20092
20102
20112
20122
20133
20141
20153
20163
20171
20184
20191
20202
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated6
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S9
Novartis Pharmaceuticals3
GlaxoSmithKline2
Hoffmann-La Roche2
Jazz Pharmaceuticals2
Oxurion2
Tranzyme, Inc.2
University of Oxford2
Allergan1
Astellas Pharma Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus42
Diabetes Mellitus, Type 216
Diabetes Mellitus, Type 16
Gastroparesis3
Atherosclerosis2
Diabetic Neuropathies2
Diabetic Retinopathy2
Dyslipidemias2
Endocrine System Diseases2
Fatty Liver2

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.